However, poorly differentiated cancers can be difficult ... this is the first application of ANN for diagnostic classification of cancer using gene-expression data derived from cDNA microarrays.

In a live virtual event, Thomas C. Krivak, MD, reviewed the key studies of PARP inhibitor and bevacizumab maintenance in ...

Proteomics profiling of a pre-metastatic colorectal cancer cohort identifies four proteomics-based subtypes and highlights ...

A cancer diagnosis has rocked a Hobart journalist and podcaster. Here’s why Sam Ikin is fighting for his family. Mr Ikin, 47, was diagnosed with poorly differentiated thyroid cancer (PDTC ...

The drug, also known as Truqap and made by British pharmaceutical giant AstraZeneca, helps slow or stop the progression of the cancer, meaning it could help some patients live longer. "People with ...

The drug, also known as Truqap and made by British pharmaceutical giant AstraZeneca, helps slow or stop the progression of the cancer, meaning it could help some patients live longer. "People with ...

A 'healthy' father-of-two thought he was one of the 8 million adults in the UK suffering from back pain — unaware deadly cancer had been attacking his organs for years. By the time he was ...

Because if I had not gotten my test early, I mean, I shudder to think what could have happened to me.’ Tina was diagnosed with cancer after missing her routine screening during the Covid-19 pand ...

The Act prohibits “certain advertisements relating to cancer”, meaning no one can publish any kind of advert offering to treat people for cancer, prescribe any kind of remedy for it, or publish ...

A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run National Health Service, officials said on Friday. Scientists described ...